These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21474098)

  • 1. A call for standardized naming and reporting of human ESC and iPSC lines.
    Luong MX; Auerbach J; Crook JM; Daheron L; Hei D; Lomax G; Loring JF; Ludwig T; Schlaeger TM; Smith KP; Stacey G; Xu RH; Zeng F
    Cell Stem Cell; 2011 Apr; 8(4):357-9. PubMed ID: 21474098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaching for consensus on a naming convention for pluripotent cells.
    Rust W; Pollok B
    Cell Stem Cell; 2011 Jun; 8(6):607-8. PubMed ID: 21624803
    [No Abstract]   [Full Text] [Related]  

  • 3. The nomenclature system should be sustainable, but also practical.
    Higashi H; Brüstle O; Daley GQ; Yamanaka S
    Cell Stem Cell; 2011 Jun; 8(6):606-7. PubMed ID: 21624802
    [No Abstract]   [Full Text] [Related]  

  • 4. Induced pluripotent stem cells from pigs and other ungulate species: an alternative to embryonic stem cells?
    Ezashi T; Telugu BP; Roberts RM
    Reprod Domest Anim; 2012 Aug; 47 Suppl 4():92-7. PubMed ID: 22827356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
    Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
    PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
    Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cardiomyogenic potential among human ESC and iPSC lines.
    Sepac A; Si-Tayeb K; Sedlic F; Barrett S; Canfield S; Duncan SA; Bosnjak ZJ; Lough JW
    Cell Transplant; 2012; 21(11):2523-30. PubMed ID: 22863088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
    Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
    Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective.
    Liang G; Zhang Y
    Cell Res; 2013 Jan; 23(1):49-69. PubMed ID: 23247625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?
    Stacey GN; Crook JM; Hei D; Ludwig T
    Cell Stem Cell; 2013 Oct; 13(4):385-8. PubMed ID: 24094320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells.
    Amit M; Chebath J; Margulets V; Laevsky I; Miropolsky Y; Shariki K; Peri M; Blais I; Slutsky G; Revel M; Itskovitz-Eldor J
    Stem Cell Rev Rep; 2010 Jun; 6(2):248-59. PubMed ID: 20431964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics in the World of Induced Pluripotent Stem Cells.
    Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raising the standards of stem cell line quality.
    Yaffe MP; Noggle SA; Solomon SL
    Nat Cell Biol; 2016 Mar; 18(3):236-7. PubMed ID: 26911906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated selection and harvesting of pluripotent stem cell colonies.
    Haupt S; Grützner J; Thier MC; Kallweit T; Rath BH; Laufenberg I; Forgber M; Eberhardt J; Edenhofer F; Brüstle O
    Biotechnol Appl Biochem; 2012; 59(2):77-87. PubMed ID: 23586788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells.
    Glaser DE; Turner WS; Madfis N; Wong L; Zamora J; White N; Reyes S; Burns AB; Gopinathan A; McCloskey KE
    PLoS One; 2016; 11(12):e0166663. PubMed ID: 27907001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.